Literature DB >> 18729270

[Inhibition of the VEGF receptor system with tyrosine kinase inhibitors. Angiogenesis inhibition in oncology].

Klaus Mross1.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18729270     DOI: 10.1002/pauz.200800281

Source DB:  PubMed          Journal:  Pharm Unserer Zeit        ISSN: 0048-3664


× No keyword cloud information.
  2 in total

1.  Effects of inhibitors of vascular endothelial growth factor receptor 2 and downstream pathways of receptor tyrosine kinases involving phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin or mitogen-activated protein kinase in canine hemangiosarcoma cell lines.

Authors:  Mami Adachi; Yuki Hoshino; Yusuke Izumi; Hiroki Sakai; Satoshi Takagi
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

2.  Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.

Authors:  Markus Moehler; Irina Gepfner-Tuma; Annett Maderer; Peter C Thuss-Patience; Joern Ruessel; Susanna Hegewisch-Becker; Hansjochen Wilke; Salah-Eddin Al-Batran; Mohammad-Reza Rafiyan; Florian Weißinger; Hans-Joachim Schmoll; Frank Kullmann; Ludwig Fischer von Weikersthal; Jens T Siveke; Jens Weusmann; Stephan Kanzler; Carl Christoph Schimanski; Melanie Otte; Lukas Schollenberger; Jochem Koenig; Peter R Galle
Journal:  BMC Cancer       Date:  2016-08-31       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.